Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000947871-25-000392
Filing Date
2025-04-14
Accepted
2025-04-14 19:14:36
Documents
1
Period of Report
2025-04-10

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 8095
  Complete submission text file 0000947871-25-000392.txt   10397
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Reporting) CIK: 0001055951 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 001-34951 | Film No.: 25837169

Mailing Address 664 CRUISER LANE BELGRADE MT 59714
Business Address 664 CRUISER LANE BELGRADE MT 59714 406-388-0480
Xtant Medical Holdings, Inc. (Issuer) CIK: 0001453593 (see all company filings)

EIN.: 205313323 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 601 LEXINGTON AVE., 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVE., 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
Orbimed ROF II LLC (Reporting) CIK: 0001767936 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34951 | Film No.: 25837168